¿´Æ¬ÊÓÆµ

Object moved to here.

¿´Æ¬ÊÓÆµ :: Pilot & Feasibility Program Application

¿´Æ¬ÊÓÆµ


Increased small vessel disease in the brain and cognitive impairment in diabetes
Summary Data Summary
Applicant Li, Weiguo
E-Mail Address liwe@musc.edu
Project Title Increased small vessel disease in the brain and cognitive impairment in diabetes
CBU ID 17AU3831
External SubContract ID 32307-42
Diabetic Complication Neuropathy & Neurocognition
Funding Program Group Pilot & Feasibility [PF2017]
Abstract Diabetes is an increasing risk factor for vascular cognitive impairment (VCI),
which is defined as cognitive deficits associated with small vessel disease
(SVD) and/or lacunar infarction due to the occlusion of terminal arterioles by
emboli in the brain. Microemboli even in sizes that would not cause complete
occlusion are quite common in the cerebral circulation and are more so in
patients with diabetes that present with a hypercoagulable state. Lack of
understanding of the role and mechanisms by which microemboli can contribute to
increased disease burden in diabetes is a critical gap in our knowledge. The
objectives of this ¿´Æ¬ÊÓÆµ Pilot & Feasibility Program grant application are to
begin addressing this important clinical problem by establishing a novel animal
model and gathering proof-of-concept data to implicate the vascular dysfunction
and microemboli interaction in the development of cerebral SVD preceding the VCI
in diabetes. We propose that the microemboli injected through the internal
carotid artery will accelerate the development of cerebral SVD in diabetes
ultimately resulting in VCI without increasing microinfarcts in a sex
independent manner. We will examine the cerebral neuronal and vascular changes
by neuropathology assay in both male and female animals. We will also examine
the neurological and cognitive behavioral tests, and brain imaging to assess the
cognitive function. The results of this translational study first will provide
the proof-of-concept pilot data that microemboli are pathological even in the
absence of increased microinfarction in diabetes. Second, we will establish a
new clinically relevant model to study the mechanisms of VCI, which will enable
us to develop the studies on neurovascular protection strategies especially in
the high-risk groups. Third, we will provide novel data regarding the impact of
sex on the development of VCI in diabetes.
Application PDF Application Research Plan
Status Contract Executed
Key Personnel Adviye Ergul; Guangkuo Dong;
Salary Total Costs 52911
Supply Total Costs 36498
Equipment Total Costs 0
Travel/Other Total Costs 1500
Direct Costs 90909
Indirect Costs Proposed 9091
Total Costs Proposed 100000
Total Costs Approved 28289.36
Start Date 11/1/2017
End Date 11/30/2019
IFO Name Wright, Sheree
IFO E-Mail Address ogc@augusta.edu
IACUC/IRB No. 9999
IACUC/IRB Institution Augusta University
Entity ID No.
Report Request Date 12/20/2019
T1D NO
TypeCount
Invoices 3
Progress Reports 2
Data Submission


Invoices
UrlCBU IDExternal IDInstitutionDateDirectIndirectInvoiceBalancePDF
  View  17AU383132307-42Augusta University9/18/2019$6,027.98$663.07$6,691.05$0.36View PDF
  View  17AU383132307-42Augusta University6/18/2019$11,440.05$1,258.41$12,698.46$0.36View PDF
  View  17AU383132307-42Augusta University1/16/2020$8,249.97$649.52$8,899.49$0.36View PDF
Click here to cancel and return to funding program application

*Author:
*SubContract:
*Select File:

Click browse and select the file to upload.
(Please upload ONLY TXT, Image Files (not histolgy), PDF, XLS, XLSX, DOC, or DOCX files.)